Assignee
ALETA BIOTHERAPEUTICS INC
US·7 granted patents·6 pending applications·15 citations·filing 2016–2023
Top patents by PatentIndex Score
13 records- 0194US10508143B1Compositions and methods for treatment of cancerALETA BIOTHERAPEUTICS INC·Filed 2016·Granted Dec 17, 2019·7 cites·4 claims
- 0290US10066023B2Compositions and methods for tumor transductionALETA BIOTHERAPEUTICS INC·Filed 2016·Granted Sep 4, 2018·3 cites·16 claims
- 0388US10669349B2Compositions and methods for treatment of cancerALETA BIOTHERAPEUTICS INC·Filed 2017·Granted Jun 2, 2020·2 cites·12 claims
- 0485US10072094B2Compositions and methods for tumor transductionALETA BIOTHERAPEUTICS INC·Filed 2017·Granted Sep 11, 2018·2 cites·28 claims
- 0584US11059904B2Compositions and methods for tumor transductionALETA BIOTHERAPEUTICS INC·Filed 2018·Granted Jul 13, 2021·1 cites·29 claims
- 0669US11807691B2Compositions and methods for treatment of cancerALETA BIOTHERAPEUTICS INC·Filed 2020·Granted Nov 7, 2023·0 cites·15 claims
- 0764US2026027203A1Compositions and methods for treatment of cancerALETA BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0855US2023220095A1Compositions and methods for treatment of cancerALETA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0955US2022112292A1Single domain antibodies against cll-1ALETA BIOTHERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1050US2022387487A1Compositions and methods for treatment of cancerALETA BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1148US11891426B2CD19 variantsALETA BIOTHERAPEUTICS INC·Filed 2018·Granted Feb 6, 2024·0 cites·10 claims
- 1248US2020306375A1Compositions and methods for tumor transductionALETA BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1348US2021130494A1Compositions and methods for treatment of cancerALETA BIOTHERAPEUTICS INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →